Managing patients with hematological malignancies during COVID-19 pandemic.

Sahu, Kamal Kant; Cerny, Jan

Sahu, Kamal Kant; Cerny, Jan.

Sahu KK; Division of Hematology and Oncology, Department of Internal Medicine, Saint Vincent Hospital , Worcester, MA, USA.
Cerny J; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Health Care, University of Massachusetts Medical School , Worcester, MA, USA.

Expert Rev Hematol ; 13(8): 787-793, 2020 08.

Article in English | MEDLINE | ID: covidwho-614130

Subject(s)

Coronavirus Infections/pathology; Hematologic Neoplasms/therapy; Pneumonia, Viral/pathology; Betacoronavirus/isolation & purification; COVID-19; Coronavirus Infections/complications; Coronavirus Infections/epidemiology; Coronavirus Infections/virology; Hematologic Neoplasms/complications; Hematologic Neoplasms/mortality; Hematologic Neoplasms/pathology; Hematopoietic Stem Cell Transplantation; Humans; Leukemia/mortality; Leukemia/pathology; Leukemia/therapy; Pandemics; Pneumonia, Viral/complications; Pneumonia, Viral/epidemiology; Pneumonia, Viral/virology; Risk Factors; SARS-CoV-2; Severity of Illness Index; Survival Rate

Keywords

COVID-19; cancer; hematology; pandemic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Hematologic Neoplasms Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Expert Rev Hematol Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: 17474086.2020.1787147

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google